Annual Interest Expense
$915.00 M
-$114.00 M-11.08%
December 31, 2024
Summary
- As of February 6, 2025, TEVA annual interest expense is $915.00 million, with the most recent change of -$114.00 million (-11.08%) on December 31, 2024.
- During the last 3 years, TEVA annual interest expense has risen by +$24.00 million (+2.69%).
- TEVA annual interest expense is now -11.08% below its all-time high of $1.03 billion, reached on December 31, 2023.
Performance
TEVA Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$224.00 M
-$48.00 M-17.65%
December 31, 2024
Summary
- As of February 6, 2025, TEVA quarterly interest expense is $224.00 million, with the most recent change of -$48.00 million (-17.65%) on December 31, 2024.
- Over the past year, TEVA quarterly interest expense has dropped by -$26.00 million (-10.40%).
- TEVA quarterly interest expense is now -67.86% below its all-time high of $697.00 million, reached on September 30, 2015.
Performance
TEVA Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$987.00 M
+$3.00 M+0.30%
December 31, 2024
Summary
- As of February 6, 2025, TEVA TTM interest expense is $987.00 million, with the most recent change of +$3.00 million (+0.30%) on December 31, 2024.
- Over the past year, TEVA TTM interest expense has dropped by -$32.00 million (-3.14%).
- TEVA TTM interest expense is now -13.50% below its all-time high of $1.14 billion, reached on September 30, 2021.
Performance
TEVA TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
TEVA Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.1% | -10.4% | -3.1% |
| 3 y3 years | +2.7% | +6.2% | +24.0% |
| 5 y5 years | +11.3% | -33.3% | +9.7% |
TEVA Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.1% | +2.7% | -20.0% | +160.5% | -4.1% | +24.0% |
| 5 y | 5-year | -11.1% | +11.3% | -33.3% | +160.5% | -13.5% | +31.4% |
| alltime | all time | -11.1% | +353.0% | -67.9% | +133.9% | -13.5% | +1022.4% |
Teva Pharmaceutical Industries Limited Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $915.00 M(-11.1%) | $224.00 M(-17.6%) | $987.00 M(+0.3%) |
| Sep 2024 | - | $272.00 M(+12.9%) | $984.00 M(-0.8%) |
| Jun 2024 | - | $241.00 M(-3.6%) | $992.00 M(-2.6%) |
| Mar 2024 | - | $250.00 M(+13.1%) | $1.02 B(-1.0%) |
| Dec 2023 | $1.03 B(+10.6%) | $221.00 M(-21.1%) | $1.03 B(+1.2%) |
| Sep 2023 | - | $280.00 M(+4.5%) | $1.02 B(+2.8%) |
| Jun 2023 | - | $268.00 M(+3.1%) | $989.00 M(+6.1%) |
| Mar 2023 | - | $260.00 M(+24.4%) | $932.00 M(+0.2%) |
| Dec 2022 | $930.00 M(+4.4%) | $209.00 M(-17.1%) | $930.00 M(+15.2%) |
| Sep 2022 | - | $252.00 M(+19.4%) | $807.00 M(+1.4%) |
| Jun 2022 | - | $211.00 M(-18.2%) | $796.00 M(-7.3%) |
| Mar 2022 | - | $258.00 M(+200.0%) | $859.00 M(-3.6%) |
| Dec 2021 | $891.00 M(-1.1%) | $86.00 M(-64.3%) | $891.00 M(-21.9%) |
| Sep 2021 | - | $241.00 M(-12.0%) | $1.14 B(+12.2%) |
| Jun 2021 | - | $274.00 M(-5.5%) | $1.02 B(+5.3%) |
| Mar 2021 | - | $290.00 M(-13.7%) | $966.00 M(+7.3%) |
| Dec 2020 | $901.00 M(+9.6%) | $336.00 M(+187.2%) | $900.00 M(+19.8%) |
| Sep 2020 | - | $117.00 M(-47.5%) | $751.00 M(-11.1%) |
| Jun 2020 | - | $223.00 M(-0.4%) | $845.00 M(+2.1%) |
| Mar 2020 | - | $224.00 M(+19.8%) | $828.00 M(+0.7%) |
| Dec 2019 | $822.00 M(-10.7%) | $187.00 M(-11.4%) | $822.00 M(+0.4%) |
| Sep 2019 | - | $211.00 M(+2.4%) | $819.00 M(-2.2%) |
| Jun 2019 | - | $206.00 M(-5.5%) | $837.00 M(-3.5%) |
| Mar 2019 | - | $218.00 M(+18.5%) | $867.00 M(-5.8%) |
| Dec 2018 | $920.00 M(+5.1%) | $184.00 M(-19.7%) | $920.00 M(+1.4%) |
| Sep 2018 | - | $229.00 M(-3.0%) | $907.00 M(-3.2%) |
| Jun 2018 | - | $236.00 M(-12.9%) | $937.00 M(-0.2%) |
| Mar 2018 | - | $271.00 M(+58.5%) | $939.00 M(+7.3%) |
| Dec 2017 | $875.00 M(+60.3%) | $171.00 M(-34.0%) | $875.00 M(+25.5%) |
| Sep 2017 | - | $259.00 M(+8.8%) | $697.00 M(+18.5%) |
| Jun 2017 | - | $238.00 M(+15.0%) | $588.00 M(+29.2%) |
| Mar 2017 | - | $207.00 M(-3057.1%) | $455.00 M(-16.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $546.00 M(+102.2%) | -$7.00 M(-104.7%) | $546.00 M(-610.3%) |
| Sep 2016 | - | $150.00 M(+42.9%) | -$107.00 M(-124.3%) |
| Jun 2016 | - | $105.00 M(-64.8%) | $440.00 M(+17.0%) |
| Mar 2016 | - | $298.00 M(-145.2%) | $376.00 M(+39.3%) |
| Dec 2015 | $270.00 M(-10.0%) | -$660.00 M(-194.7%) | $270.00 M(-72.6%) |
| Sep 2015 | - | $697.00 M(+1600.0%) | $987.00 M(+163.9%) |
| Jun 2015 | - | $41.00 M(-78.6%) | $374.00 M(-9.0%) |
| Mar 2015 | - | $192.00 M(+236.8%) | $411.00 M(+37.0%) |
| Dec 2014 | $300.00 M(-4.5%) | $57.00 M(-32.1%) | $300.00 M(+38.2%) |
| Sep 2014 | - | $84.00 M(+7.7%) | $217.00 M(+3.8%) |
| Jun 2014 | - | $78.00 M(-3.7%) | $209.00 M(-5.0%) |
| Mar 2014 | - | $81.00 M(-411.5%) | $220.00 M(-29.9%) |
| Dec 2013 | $314.00 M(-11.5%) | -$26.00 M(-134.2%) | $314.00 M(-31.0%) |
| Sep 2013 | - | $76.00 M(-14.6%) | $455.00 M(+0.7%) |
| Jun 2013 | - | $89.00 M(-49.1%) | $452.00 M(-1.7%) |
| Mar 2013 | - | $175.00 M(+52.2%) | $460.00 M(+29.6%) |
| Dec 2012 | $355.00 M(+51.7%) | $115.00 M(+57.5%) | $355.00 M(-8.7%) |
| Sep 2012 | - | $73.00 M(-24.7%) | $389.00 M(+1.6%) |
| Jun 2012 | - | $97.00 M(+38.6%) | $383.00 M(+33.9%) |
| Mar 2012 | - | $70.00 M(-53.0%) | $286.00 M(+12.6%) |
| Dec 2011 | $234.00 M(+15.8%) | $149.00 M(+122.4%) | $254.00 M(+96.9%) |
| Sep 2011 | - | $67.00 M(+76.3%) | $129.00 M(-39.4%) |
| Mar 2011 | - | $38.00 M(+58.3%) | $213.00 M(+5.4%) |
| Dec 2010 | $202.00 M(0.0%) | $24.00 M(+700.0%) | $202.00 M(-1.0%) |
| Sep 2010 | - | $3.00 M(-98.0%) | $204.00 M(-19.4%) |
| Jun 2010 | - | $148.00 M(+448.1%) | $253.00 M(+52.4%) |
| Mar 2010 | - | $27.00 M(+3.8%) | $166.00 M(-17.8%) |
| Dec 2009 | $202.00 M(-36.5%) | $26.00 M(-50.0%) | $202.00 M(+14.8%) |
| Sep 2009 | - | $52.00 M(-14.8%) | $176.00 M(+41.9%) |
| Jun 2009 | - | $61.00 M(-3.2%) | $124.00 M(+96.8%) |
| Mar 2009 | - | $63.00 M | $63.00 M |
| Dec 2008 | $318.00 M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual interest expense?
- What is the all time high annual interest expense for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual interest expense year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly interest expense?
- What is the all time high quarterly interest expense for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly interest expense year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM interest expense?
- What is the all time high TTM interest expense for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM interest expense year-on-year change?
What is Teva Pharmaceutical Industries Limited annual interest expense?
The current annual interest expense of TEVA is $915.00 M
What is the all time high annual interest expense for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual interest expense is $1.03 B
What is Teva Pharmaceutical Industries Limited annual interest expense year-on-year change?
Over the past year, TEVA annual interest expense has changed by -$114.00 M (-11.08%)
What is Teva Pharmaceutical Industries Limited quarterly interest expense?
The current quarterly interest expense of TEVA is $224.00 M
What is the all time high quarterly interest expense for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly interest expense is $697.00 M
What is Teva Pharmaceutical Industries Limited quarterly interest expense year-on-year change?
Over the past year, TEVA quarterly interest expense has changed by -$26.00 M (-10.40%)
What is Teva Pharmaceutical Industries Limited TTM interest expense?
The current TTM interest expense of TEVA is $987.00 M
What is the all time high TTM interest expense for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM interest expense is $1.14 B
What is Teva Pharmaceutical Industries Limited TTM interest expense year-on-year change?
Over the past year, TEVA TTM interest expense has changed by -$32.00 M (-3.14%)